Abstract # 2303
A Pretreatment PSA Level of 7 to 10 Ng/ml is an Independent Predictor of Adverse Biochemical Disease Free Survival among Low Risk Prostate Cancer Patients Treated with I-125 Brachytherapy
Presenter:
Cesaretti, Jamie
< Back to topics
>
Cover Page, Authors, Institutions
>
Purpose/Objective
>
Materials/Methods
>
Results/Discussion
>
Conclusions
>
View tables/images/videos
>
View abstract & virtual poster in original format
Purpose/Objective:
Click on images to enlarge (a new pop-up window will open)
Treatment of Low Risk Prostate Cancer:
